Han S, Munawar U, Truger M, Gerhard-Hartmann E, Verbruggen C, Pfeiffer L, Hainold A-S, Kurian S, Nerreter S, Besant E, Vogt C, Rein N, Köppel M, Lehmann J, Schmitt F, Tamamushi Y, Zhou X, Steinbrunn T, Haferlach C, Rosenwald A, Einsele H, Rasche L, Waldschmidt JM, Kortüm MK. Promoter hypermethylation as a reversible mechanism of resistance to GPRC5D-directed therapy in multiple myeloma. haematol [Internet]. 2020Sep.10 [cited 2026Jan.11];. Available from: https://haematologica.org/article/view/13085